All Articles

The iconic bakery brand is making a strategic pivot into the massive on-the-go snacking market with its new pretzel bites, a move that redefines convenience.

Analyst firm QKS Group names Compass Plus a leader, but the real story is how its modern, API-first architecture is rewiring card payments for banks.

A landmark survey reveals a stunning bipartisan mandate on reproductive health, showing a vast majority of Republican voters support protecting access to EC.

The sudden death of veteran counsel E. Forrest Jones Jr. leaves a void at Ramaco Resources, testing its leadership amid a high-stakes pivot to critical minerals.

The age of SEO is over. A new report reveals AI now curates what we buy based on a brand's total internet presence, not just its ads. Welcome to the Recommendation Era.

With its stock lagging despite strong sales, Insulet brings on a proven value-creator. Can the 'Mazelsky Playbook' accelerate growth and fend off rivals?

By fast-tracking its novel oral drug for atopic dermatitis, Kymera isn't just advancing a treatment—it's validating a new class of medicine.

China's data center giant GDS secures a massive war chest and reshuffles its board, signaling an aggressive push to dominate the AI infrastructure boom.

Verano's upcoming Q2 report is a key indicator for the cannabis sector. We look at the strategic moves, from stock splits to rescheduling, setting the stage.

Tiziana Life Sciences has dosed the final patient in a key trial for its nasal MS drug, foralumab. With data imminent, this could be a breakthrough for an untreatable form of the disease.

FlightHub is expanding from flights to a full-service travel platform. But can its new hotel booking service truly challenge giants like Expedia and Booking.com?

With late-stage veterans on board, MRM Health isn't just advancing a drug; it's building the strategic architecture for microbiome's leap from lab to market.

A landmark publication in The Lancet unveils AC01, a novel oral drug that safely improves heart function, offering a beacon of hope for millions with heart failure.

Promising 3-year survival data for a novel immunotherapy combo offers new hope for patients with MSS colorectal cancer, a notoriously difficult disease.

UpDoc just secured the first FDA clearance for a patient-facing clinical AI. This isn't just another app; it's a new paradigm for healthcare delivery.

Aidoc's 'First Read' AI has earned a coveted FDA Breakthrough designation, promising to ease radiologist workload. But can an algorithm be trusted with your health?

By offering free Starlink Wi-Fi, Alaska Air Group isn't just upgrading a service; it's weaponizing connectivity to win loyalty and challenge rivals.

Beyond the music, the 2026 CCMA Awards reveal a powerful synergy between city branding, artist entrepreneurship, and integrated media strategy. A new blueprint?

A new player is spending big to bring multi-gig internet to Chicagoland. But in a crowded market, Ezee Fiber's real test isn't speed—it's strategy.